Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
NVO · against 24 other Healthcare companies of similar size
Ranked #1 of 25 · scores higher than 100% of peers
Bars: peers in each 10-point band of the valuation score1 peers with a valuation score of 90–100, including NVO · Click a bar to see the companies
Mainly thanks to its earnings yield, EBITDA yield and free cash flow yield, which are stronger than most Healthcare peers.
| Metric | NVO | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 25 reported | 10.0% | 3.8% | 100% | 30% | |
| EBITDA yieldHigher is better · 25 reported | 13.7% | 6.6% | 100% | 50% | |
| Free cash flow yieldHigher is better · 24 reported | 4.1% | 4.9% | 43% | 20% | |
| Book yieldHigher is better · 23 reported | 16.6% | 20.1% | 36% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 177.5B USD | 92 | 71 | |
| 2 | 108.6B USD | 88 | 66 | |
| 3 | 97.5B USD | 87 | 67 | |
| 4 | 126.1B USD | 83 | 62 | |
| 4 | 540.4B BRL (≈$97.3B) | 83 | 64 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score